Time New York: Sat 03 Dec 01:50 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Recro Pharma (REPH) in Focus: Stock Moves 19.8% Higher

Zacks

Recro Pharma, Inc. REPH was a big mover last session, as its shares rose almost 20% on the day. The move came after the company announced positive phase 3 trial results for its acute postoperative pain treatment. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.92 to $8.71 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive and two negative estimate revisions while the Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Recro Pharma currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

RECRO PHARMA Price


RECRO PHARMA Price | RECRO PHARMA Quote

A better-ranked stock in the medical-drugs space is Sucampo Pharmaceuticals, Inc. SCMP, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is REPH going up? Or down? Predict to see what others think: Up or Down

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.